Psychedelic drugs could soon play a larger role in mental health care. Over the weekend, President Donald Trump signed an executive order aimed at boosting federal research into substances like psilocybin, LSD and MDMA and expanding their use in controlled treatment settings.
This article was originally published on MedicalXpress.com

